Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples